Full Access
Continuous infusion instead of bolus injections of factor concentrate?
S. SCHULMAN,
U. MARTINOWITZ,
S. SCHULMAN
The National Haemophilia Centre, The Chaim Sheba Medical Centre, Tel Hashomer 52621, Israel
Search for more papers by this authorU. MARTINOWITZ
The National Haemophilia Centre, The Chaim Sheba Medical Centre, Tel Hashomer 52621, Israel
Search for more papers by this authorS. SCHULMAN,
U. MARTINOWITZ,
S. SCHULMAN
The National Haemophilia Centre, The Chaim Sheba Medical Centre, Tel Hashomer 52621, Israel
Search for more papers by this authorU. MARTINOWITZ
The National Haemophilia Centre, The Chaim Sheba Medical Centre, Tel Hashomer 52621, Israel
Search for more papers by this author
References
- 1 Schulman S.. DDAVP – the multipotent drug in patients with coagulopathies. Trans Med Rev, 1991; 5: 132–44.
- 2 Gerrard AJ, Austen DEG, Brownlec GG. Subcutaneous injection of factor IX for the treatment of haemophilia B. Br J Haematol, 1992; 81: 610–3.
- 3 Berrettini M., Iorio P., Nenci GG, Arcieri P., Mariani G.. Subcutaneous factor IX administration to patients with hemophilia B. Am J Hematol, 1994; 47: 61–2.
- 4 Lindley CM, Sawyer WT, Macik BG, et al. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa. Clin Pharmacol Ther, 1994; 55: 638–48.
- 5 Schulman S., Varon D., Keller N., Giltel S., Martinowitz U.. Monoclonal purified F VIII for continuous infusion: Stability, microbiological safety and clinical experience. Thromb Haemostas, 1994; 72: 403–7.
- 6 Varon D., Schulman S., Beshari D., Martinowitz U.. Home therapy with continuous infusion of factor VIII after minor surgery or serious haemorrhage.
- 7 Gordon EM, Mungo R., Goldsmith JC. Lingual hemorrhage in a patient with hemophilia A complicated by a high titer inhibitor. Am J Pediatr Hematol Oncol, 1993; 15: 107–10.
- 8 Hermens WTH. Dose calculation of human factor VIII factor IX concentrates for infusion therapy. In: KM Brinkhouse, HC Hemker, eds. Handbook of Hemophilia, part II. New York : America Elsevier Publishing Co., 1975; 569–589.
- 9 Martinowitz U., Schulman S., Gitel S., Horoszowski H., Heim M., Varon D.. Adjusted dose continuous infusion of factor VIII in patients with haemophilia A. Br J Haematol, 1992; 82: 729–34.
- 10 Schulman S., Gitel S., Zivelin A., et al. The feasibility of using concentrates containing factor IX for continuous infusion. Haemophilia, 1995; 1: 103–10.
- 11 Schulman S., Bech Jensen M., Varon D., et al. Feasibility of using recombinant factor VIIa in continuous infusion. Thromb Haemostas.
- 12 Martinowitz, U., Schulman S.. Continuous infusion of coagulation products. Int J Pediatr Hematol Oncol, 1994; 1: 471–8.
- 13 Schulman S., Gitel S., Martinowitz U.. The stability of factor VIII concentrates after reconstitution. Am J Hematol, 1994; 45: 217–23.
- 14 Martinowitz U., Schulman S.. Review of pumps for continuous infusion of coagulation factor concentrates: what are the options Blood Coag Fibrinol, 1996; 6: (Suppl 1): in press.
- 15 Gribble TJ, Jones JE, Chapelle JA, Vaughan LJ, Friedman KD. Continuous infusion of factor VIII as part of an immune tolerance induction program. Thromb Haemostas, 1995; 73: 1024 (abstract).
- 16 Nilsson IM, Berntorp E., Löfqvist T., Pettersson H.. Twentyfive years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med, 1992; 232: 25–32.
Citing Literature
